Skip to main content
Caplight Logo









Skeletalis Bio

Skeletalis Bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://skeletalis.bio

Last Round

Seed

Nov 17, 2025

Total Funding Raised

$8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Skeletalis Bio operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in November 2025.

Skeletalis Bio is a biotechnology company developing a platform of targeted small-molecule therapeutics for treating osteoporosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Skeletalis Bio Comparables

Compare Skeletalis Bio with similar companies based on industry and business-model similarity.

Skeletalis Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apasomics
88%
Taithera, Inc.
85%
Mesentech Inc.
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Skeletalis Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 17, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Skeletalis Bio Investors

Notable investors and investment history

Skeletalis Bio investors
InvestorRounds
age1Seed
Pillar VCSeed
KdT VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 17, 2025

    Raised $8M in a Seed round.

Book a demo to see all signals

For institutional investors. Book with your work email.

Skeletalis Bio Filings

Explore SEC and related filing metadata, where available.

Skeletalis Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Skeletalis Bio's valuation, stock price, and market status.

Is Skeletalis Bio a public or private company?

Skeletalis Bio is a private company.

What is the current stock price of Skeletalis Bio?

Skeletalis Bio is a private company, so its shares have no public market price. Caplight tracks Skeletalis Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Skeletalis Bio worth (valuation)?

Valuation information for Skeletalis Bio is not publicly available.

Can I buy Skeletalis Bio stock?

Skeletalis Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Skeletalis Bio's last funding round?

Skeletalis Bio's most recent funding round was Seed on November 17, 2025.

Who are the main investors in Skeletalis Bio?

Key investors in Skeletalis Bio include Pillar VC.

Will Skeletalis Bio IPO soon?

No public IPO plans have been announced for Skeletalis Bio.

How can I track Skeletalis Bio secondary market activity?

Caplight tracks bids, offers, and trades in Skeletalis Bio's shares on secondary markets.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range6
Year Founded2025
Last FundingNov 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?